{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:45:26Z","timestamp":1781909126472,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To validate the Society of Urodynamics, Female Pelvic Medicine &amp; Urogenital Reconstruction (SUFU) Best Practice Policy Statement (BPPS) risk factors (RFs) for predicting urinary-tract infection (UTI) after urodynamic study (UDS) and to identify possible RFs that could better guide antibiotic prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study included all adults undergoing UDS at a single institution. Patients with asymptomatic bacteriuria received a 3-day antibiotic course, while those without bacteriuria received no prophylaxis. The primary endpoint was a culture-confirmed UTI within 7 days. Regression analysis was performed to check SUFU BPPS RFs as predictors for post-UDS UTI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1666 patients (median age 68 years; 42% female), UTI occurred in 31 (1.9%). Abnormal GU anatomy was found as a predictor for post-UDS UTI (OR\u2009=\u20093.26,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033). Other examined RFs were not found to predict post-UDS UTI. More concise variables were identified as statistically significant predictors: hydronephrosis (OR\u2009=\u20094.98,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), elevated post-void residual (PVR) (OR\u2009=\u20092.80,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), and NLUTD due to neurologic disease (OR\u2009=\u20092.27,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.042). In multivariate analysis, elevated PVR and NLUTD caused by neurologic disease remained independent predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The current SUFU BPPS criteria exhibit limited accuracy for predicting post-UDS UTI. Our study emphasizes hydronephrosis, NLUTD caused by neurologic disease, and elevated PVR as predictors of post-UDS UTI. Updating prophylactic guidelines to incorporate these findings could enhance patient safety and antimicrobial stewardship without compromising infection control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-025-05979-6","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T09:29:40Z","timestamp":1759570180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Does SUFU\u2019s best practice policy statement regarding antibiotic prophylaxis predict urinary tract infection after urodynamic study?"],"prefix":"10.1007","volume":"43","author":[{"given":"Omri","family":"Schwarztuch Gildor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Itshak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rony","family":"Vainrib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vainrib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"5979_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.kjms.2012.06.001","volume":"29","author":"C G\u00fcrb\u00fcz","year":"2013","unstructured":"G\u00fcrb\u00fcz C, G\u00fcner B, At\u0131\u015f G et al (2013) Are prophylactic antibiotics necessary for urodynamic study? Kaohsiung J Med Scie 29:325\u2013329. https:\/\/doi.org\/10.1016\/j.kjms.2012.06.001","journal-title":"Kaohsiung J Med Scie"},{"key":"5979_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1046\/j.1464-410X.2002.02770.x","volume":"89","author":"I Okorocha","year":"2002","unstructured":"Okorocha I, Cumming G, Gould I (2002) Female urodynamics and lower urinary tract infection. BJU Int 89:863\u2013867. https:\/\/doi.org\/10.1046\/j.1464-410X.2002.02770.x","journal-title":"BJU Int"},{"key":"5979_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1464-410x.1999.00924.x","volume":"83","author":"D Bombieri","year":"1999","unstructured":"Bombieri D, Rienhardt, et al (1999) Urinary tract infection after urodynamic studies in women: incidence and natural history. BJU Int 83:392\u2013395. https:\/\/doi.org\/10.1046\/j.1464-410x.1999.00924.x","journal-title":"BJU Int"},{"key":"5979_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/jgid.jgid_104_17","volume":"10","author":"R Paul","year":"2018","unstructured":"Paul R (2018) State of the globe: rising antimicrobial resistance of pathogens in urinary tract infection. J Global Infect Dis 10:117. https:\/\/doi.org\/10.4103\/jgid.jgid_104_17","journal-title":"J Global Infect Dis"},{"key":"5979_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.22088\/cjim.11.1.100","volume":"11","author":"Z Ghanbari","year":"2020","unstructured":"Ghanbari Z, Haghollahi F, Eftekhr T et al (2020) Rate of urinary tract infection after urodynamic study in pelvic floor clinic. Casp J Intern Med 11:100\u2013104. https:\/\/doi.org\/10.22088\/cjim.11.1.100","journal-title":"Casp J Intern Med"},{"key":"5979_CR6","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.juro.2012.09.081","volume":"188","author":"JC Winters","year":"2012","unstructured":"Winters JC, Dmochowski RR, Goldman HB et al (2012) Urodynamic studies in adults: AUA\/SUFU guideline. J Urol 188:2464\u20132472. https:\/\/doi.org\/10.1016\/j.juro.2012.09.081","journal-title":"J Urol"},{"key":"5979_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/nau.23253","volume":"36","author":"AP Cameron","year":"2017","unstructured":"Cameron AP, Campeau L, Brucker BM et al (2017) Best practice policy statement on urodynamic antibiotic prophylaxis in the non-index patient. Neurourol Urodyn 36:915\u2013926. https:\/\/doi.org\/10.1002\/nau.23253","journal-title":"Neurourol Urodyn"},{"issue":"25","key":"5979_CR8","doi-asserted-by":"publisher","first-page":"00650","DOI":"10.1016\/j.urology.2025.07.001","volume":"0090\u20134295","author":"O Schwarztuch Gildor","year":"2025","unstructured":"Schwarztuch Gildor O, Yosef E, Levin N et al (2025) Antibiotic prophylaxis before urodynamics: a urine Culture-Based versus Risk-Factors-Based protocol to minimize usage in the era of antibiotic resistance. Urol S 0090\u20134295(25):00650\u201300658. https:\/\/doi.org\/10.1016\/j.urology.2025.07.001","journal-title":"Urol S"},{"key":"5979_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.urology.2022.11.005","volume":"172","author":"J Chavarriaga","year":"2023","unstructured":"Chavarriaga J, Villanueva J, Varela D et al (2023) Do we need a urine culture before cystoscopy? Time to shift away from routine testing. Urology 172:13\u201317","journal-title":"Urology"},{"key":"5979_CR10","doi-asserted-by":"publisher","first-page":"102840","DOI":"10.1016\/j.fjurol.2024.102840","volume":"35","author":"S Gendron","year":"2025","unstructured":"Gendron S, Sie M, Delchet O et al (2025) Impact of untreated positive urine culture on urinary tract infections after cystoscopy. Fr J Urol 35:102840","journal-title":"Fr J Urol"},{"key":"5979_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/JU.0000000000000509","volume":"203","author":"DJ Lightner","year":"2020","unstructured":"Lightner DJ, Wymer K, Sanchez J, Kavoussi L (2020) Best practice statement on urologic procedures and antimicrobial prophylaxis. J Urol 203:351\u2013356. https:\/\/doi.org\/10.1097\/JU.0000000000000509","journal-title":"J Urol"},{"key":"5979_CR12","doi-asserted-by":"publisher","unstructured":"Snow-Lisy DC, Halline C, Johnson EK et al (2017) Reassessing the utility of routine urine culture with urodynamics: UTI incidence and risk factors. J Pediatr Urol 13. https:\/\/doi.org\/10.1016\/j.jpurol.2017.05.013. :372.e1-372.e8","DOI":"10.1016\/j.jpurol.2017.05.013"},{"key":"5979_CR13","first-page":"996","volume":"19","author":"N Liu","year":"2013","unstructured":"Liu N, Chen M, Chen S-Q et al (2013) Preventive administration of antibiotics to patients with benign prostatic hyperplasia before urodynamic examination. Zhonghua Nan Ke Xue 19:996\u2013998","journal-title":"Zhonghua Nan Ke Xue"},{"key":"5979_CR14","first-page":"883","volume":"41","author":"A \u015e\u0130M\u015e\u0130R","year":"2011","unstructured":"\u015e\u0130M\u015e\u0130R A, Mammadov R, Kizilay F, \u00d6zyurt MC (2011) The need for antibiotic prophylaxis before urodynamic studies. Turk J Med Sci 41:883\u2013887","journal-title":"Turk J Med Sci"},{"key":"5979_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.juro.2017.01.075","volume":"198","author":"JT Stoffel","year":"2017","unstructured":"Stoffel JT, Peterson AC, Sandhu JS et al (2017) AUA white paper on nonneurogenic chronic urinary retention: consensus Definition, treatment Algorithm, and outcome end points. J Urol 198:153\u2013160. https:\/\/doi.org\/10.1016\/j.juro.2017.01.075","journal-title":"J Urol"},{"key":"5979_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00345-011-0725-9","volume":"30","author":"CF Heyns","year":"2012","unstructured":"Heyns CF (2012) Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol 30:77\u201383. https:\/\/doi.org\/10.1007\/s00345-011-0725-9","journal-title":"World J Urol"},{"key":"5979_CR17","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/nau.24478","volume":"39","author":"C Fox","year":"2020","unstructured":"Fox C, Kim MJ, Kuo Y, Fromer DL (2020) Validation of the best practice policy statement on urodynamic antibiotic prophylaxis for the high-risk patient in the era of antibiotic stewardship. Neurourol Urodyn 39:2246\u20132252. https:\/\/doi.org\/10.1002\/nau.24478","journal-title":"Neurourol Urodyn"},{"key":"5979_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.urols.2016.11.010","volume":"28","author":"M Nadeem","year":"2017","unstructured":"Nadeem M, Sheikh MI, Sait MS et al (2017) Is urinary tract infection after urodynamic study predictable? Urol Sci 28:240\u2013242. https:\/\/doi.org\/10.1016\/j.urols.2016.11.010","journal-title":"Urol Sci"},{"key":"5979_CR19","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/nau.25516","volume":"43","author":"J Van Beek","year":"2024","unstructured":"Van Beek J, Sobhani H, W\u00f6llner J et al (2024) Patient-reported signs and symptoms of urinary tract infections after video\u2010urodynamic studies in individuals with neurogenic lower urinary tract dysfunction\u2014A single\u2010center observational study. Neurourol Urodyn 43:1609\u20131616. https:\/\/doi.org\/10.1002\/nau.25516","journal-title":"Neurourol Urodyn"},{"key":"5979_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5489\/cuaj.2382","volume":"9","author":"M Mrkobrada","year":"2015","unstructured":"Mrkobrada M, Ying I, Mokrycke S et al (2015) CUA guidelines on antibiotic prophylaxis for urologic procedures. Can Urol Assoc J 9:13\u201322. https:\/\/doi.org\/10.5489\/cuaj.2382","journal-title":"Can Urol Assoc J"},{"key":"5979_CR21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.purol.2018.10.001","volume":"28","author":"C Egrot","year":"2018","unstructured":"Egrot C, Dinh A, Amarenco G et al (2018) Antibioprophylaxie et Bilan urodynamique: recommandations de Bonne pratique par consensus formalis\u00e9. Progr\u00e8s En Urologie 28:943\u2013952. https:\/\/doi.org\/10.1016\/j.purol.2018.10.001","journal-title":"Progr\u00e8s En Urologie"},{"key":"5979_CR22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/JU.0000000000002235","volume":"206","author":"DA Ginsberg","year":"2021","unstructured":"Ginsberg DA, Boone TB, Cameron AP et al (2021) The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol 206:1097\u20131105. https:\/\/doi.org\/10.1097\/JU.0000000000002235","journal-title":"J Urol"},{"key":"5979_CR23","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/cid\/ciz021","volume":"68","author":"LE Nicolle","year":"2019","unstructured":"Nicolle LE, Gupta K, Bradley SF et al (2019) Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the infectious diseases society of Americaa. Clin Infect Dis 68:1611\u20131615. https:\/\/doi.org\/10.1093\/cid\/ciz021","journal-title":"Clin Infect Dis"},{"key":"5979_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F et al (2024) European association of urology guidelines on urological infections: summary of the 2024 guidelines. Eur Urol 86:27\u201341. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.035","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05979-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05979-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:04:31Z","timestamp":1767999871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05979-6"}},"subtitle":["Evidence from a retrospective cohort"],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5979"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05979-6","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"596"}}